1019642-47-7
Chemical Structure
CD22L-N3
Synonym(s): BPC-Sia-LacNAc-N3
- CAS 番号: 1019642-47-7
- Formula:C40H54N6O19
- Molecular Weight:922.90
IUPAC Name: (2R,4S,5R,6R)-6-((1R,2R)-3-([1,1'-biphenyl]-4-carboxamido)-1,2-dihydroxypropyl)-5-acetamido-2-(((2R,3R,4S,5R,6S)-6-(((2R,3S,4R,5R,6R)-5-acetamido-6-(2-azidoethoxy)-4-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxytetrahydro-2H-pyran-2-carboxylic acid
InChIKey: UTCPJMHBEGWJPH-LPKWDFCZSA-N
SMILES: O(C[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OCCN=[N+]=[N-])[C@H](NC(C)=O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O)[C@@]3(C(O)=O)O[C@@]([C@@H]([C@@H](CNC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)O)O)([C@H](NC(C)=O)[C@@H](O)C3)[H]
Biological Activity: CD22L-N3 (BPC-Sia-LacNAc-N3) is a pharmaceutical intermediate that can be used to synthesize CD22-specific trisaccharide ligands. CD22L-N3 is applicable to the research of B-cell lymphoma[1].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CD22L-N3 | CD22L-N3 (BPC-Sia-LacNAc-N3) is a pharmaceutical intermediate that can be used to synthesize CD22-specific trisaccharide ligands. CD22L-N3 is applicable to the research of B-cell lymphoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
